Villejuif, France

David Machover


 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of David Machover

Introduction

David Machover is a notable inventor based in Villejuif, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compositions. His work focuses on methods that utilize specific polypeptides to combat cancer effectively.

Latest Patents

David Machover holds 1 patent related to his groundbreaking work. The patent describes methods and pharmaceutical compositions for treating cancer, specifically involving a polypeptide that exhibits methionine gamma-lyase and homocysteinase activities. This invention highlights the potential of using such polypeptides in cancer therapy, offering new avenues for treatment.

Career Highlights

Throughout his career, David Machover has been associated with prestigious institutions such as the National Institute of Health and Medical Research (Institut National De La Sante Et De La Recherche Medicale) and the National Institute for Agronomic Research (Institut National De La Recherche Agronomique). His work in these organizations has contributed to advancements in medical research and pharmaceutical development.

Collaborations

David has collaborated with notable professionals in his field, including Pascal Bonnarme. These collaborations have fostered a productive environment for innovation and research, leading to significant advancements in cancer treatment methodologies.

Conclusion

David Machover's contributions to cancer treatment through his innovative research and patents underscore the importance of scientific inquiry in addressing critical health challenges. His work continues to inspire future advancements in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…